Navigation Links
Multidisciplinary treatment of glioblastoma multiforme can extend patient's life
Date:8/12/2010

Glioblastoma multiforme is the most common form of brain cancer; being an extremely serious type of the disease as currently, on diagnosis, the chances of survival of the patient is less than a year. In fact, its cause is not known nor the manner to prevent it. What is more, progress of patients suffering from this condition has hardly changed in 40 years, unlike other cancers such as, for example, infant leukaemia, for which the possibilities of recovery have risen dramatically.

The Hospital Universitario Donostia (at the city of Donostia-San Sebastin in the Basque province of Gipuzkoa) has incorporated a new glioblastoma multiforme treatment protocol, which could be the starting point for a more effective treatment of this type of cancer. Doctor Nicols Samprn, specialist in Neurosurgery at the hospital, has presented his PhD at the University of the Basque Country (UPV/EHU) based on the first results of the new treatment method. The work is entitled Glioblastoma multiforme. Analysis of survival and prognostic factors.

As Dr Samprn explained, each year there are between three and six cases of glioblastoma multiforme for every 100,000 inhabitants and, thereby, between 30 and 40 new cases correspond to the Hospital Donostia annually. It is not, therefore, an infrequent illness. The new protocol incorporated into the hospital analysed in this thesis puts forward a more multidisciplinary approach to the treatment of patients suffering from this type of cancer. The key figure at the hospital is the Neuro-oncological hospitalisation committee or team, on which neurosurgeons, neurologists, cancer experts, anatomical pathologists, radiologists and others serve; all specialists involved in the care of these patients. The idea is, thus, to provide a more personalised treatment and monitoring.

17 months

According to the thesis, this new multidisciplinary approach gives better survival rates; the usual average survival ra
'/>"/>

Contact: Amaia Portugal
a.portugal@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CIHR team grant to fund multidisciplinary breast cancer survivorship studies
2. Stem Cell Treatment May Offer Hope Against Fatal Skin Disorder
3. NIH award will enable design of brain tumor treatment that captures migrating cancer cells
4. New antiviral drug shows promise for dramatic improvement in hepatitis C treatment
5. New anti-viral drug shows promise for dramatic improvement in hepatitis C treatment
6. Surgery better than radiation, hormone treatments for some prostate cancer, study shows
7. Drug control efforts in Mexico reduce methamphetamine treatment admissions in Mexico and US
8. MicroRNA molecule increases number of blood stem cells, may help improve cancer treatment
9. Iron oxide nanoparticles becoming tools for brain tumor imaging and treatment
10. Ketamine Eased Depression in Treatment-Resistant Bipolar Disorder
11. New studies question vascular multiple sclerosis hypothesis and treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... (PRWEB) March 04, 2015 When people talk ... the top artists spread across numerous genres, the Houston ... the conversation. Each night during the annual livestock show and ... addition to the other activities being held at the event. ... groups of performers that will try and get the festival ...
(Date:3/4/2015)... New York (PRWEB) March 04, 2015 ... ) that allege the statin drug caused patients to ... the U.S. District Court, District of South Carolina. According ... be convened on March 26, 2015 at 10:00 a.m. ... directed to submit a Joint Status report to the ...
(Date:3/4/2015)... Falls Church, VA (PRWEB) March 04, 2015 ... in Four Hours , **FDAnews Webinar**, March 24, 2015 ... , FDA investigators generally know within four hours ... not. If the manufacturer is on their “good” list, ... they’re doing. If a manufacturer is on the “bad” ...
(Date:3/4/2015)... The ability of volumetric breast imaging ... help improve breast cancer risk prediction models is ... at the European Congress of Radiology (ECR) meeting, ... posters and 2 session presentations - highlight the ... quantitative breast imaging software tools to provide insight ...
(Date:3/4/2015)... (PRWEB) March 04, 2015 With the growing ... the lives of our teens and young adults, combined with ... difficult and confusing to try to keep up with what ... fad or trend is replaced on a daily basis. , ... substances, and the slang that is used to discreetly talk ...
Breaking Medicine News(10 mins):Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 2Health News:Cheap Houston Rodeo Tickets: Ticket Down Slashes Houston Rodeo Tickets for John Legend, Pitbull, Alan Jackson, Tim McGraw, Zac Brown Band, Fall Out Boy & Miranda Lambert 3Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 2Health News:Lipitor Lawsuit News: Bernstein Liebhard LLP Comments on Scheduling of Status Conference in Federal Lipitor Litigation 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 2Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 3Health News:FDAnews Announces: FDA’s New Inspection Approach: What Your Inspector Knows in Four Hours Webinar, March 24, 2015 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 2Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 3Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 4Health News:Research Finds Use of Volpara Solutions’ Quantitative Breast Imaging Tools Help Reduce Subjectivity in Density Assessment and Improve Breast Cancer Risk Prediction 5Health News:Per Wickstrom Offers Guide to Parents for Keeping Youth Sober 2
... Ind. - A Purdue University research team developed a ... as needed for extending the shelf life of foods ... an assistant professor of food science, altered the surface ... which led to the creation of several forms of ...
... health concerns about increasing antiviral resistance among certain influenza ... alternative antiviral treatment options. The findings are published in ... Infectious Diseases . (Please see below for links to ... two classes of drugs: M2 blockers (adamantanes) and neuraminidase ...
... has contributed to a study showing that a low dose ... study is published in today,s Lancet . , ... Rothwell in Oxford, and is based on an overview of ... with reducing heart attacks, but have also gathered information on ...
... , MONDAY, Dec. 6 (HealthDay News) -- Long-term ... of dying from a wide array of cancers, a new ... that a low-dose aspirin (75 milligrams) taken daily for at ... percent drop in fatalities depending on the type of cancer. ...
... Physical Therapy Association (APTA) is pointing to a new study ... to encourage the newly established Center for Medicare and Medicaid ... to physical therapist services that was recommended in the recent ... Spine , showed Medicare patients who received physical therapy ...
... HealthDay Reporter , MONDAY, Dec. 6 (HealthDay News) -- Applying sunscreen ... chances of getting melanoma by half, a new study has found. ... 25 to 75 into two groups. One group was told to ... for five years between 1992 and 1996. The other group was ...
Cached Medicine News:Health News:Nanoparticle gives antimicrobial ability to fight Listeria longer 2Health News:Influenza virus strains show increasing drug resistance and ability to spread 2Health News:Influenza virus strains show increasing drug resistance and ability to spread 3Health News:Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent 2Health News:Daily Aspirin Linked to Steep Drop in Cancer Risk 2Health News:Daily Aspirin Linked to Steep Drop in Cancer Risk 3Health News:Early physical therapy for low back pain associated with less subsequent health care utilization 2Health News:Daily Sunscreen Use Does Protect from Melanoma, Study Finds 2Health News:Daily Sunscreen Use Does Protect from Melanoma, Study Finds 3
(Date:3/4/2015)... 5. März 2015 Unfors ... im Bereich diagnostische Röntgenstrahlung, stellte heute ... dem European Congress of Radiology (ECR) ... Österreich, einen neuen Strahlungsüberwachungssensor vor. ... Der RaySafe X2-Überwachungssensor ...
(Date:3/4/2015)... Holdings, Inc. (NYSE: HRC ) announced today ... to its Board of Directors.  She most recently served ... as President of Covidien,s Vascular Therapies Division from 2012 to ... 2012. Ms. Enxing Seng joined Covidien in ... she was a founding member and executive officer responsible ...
(Date:3/4/2015)... , March 4, 2015  Vanda Pharmaceuticals Inc. ... top-line results of the Phase II proof of ... of tradipitant as a monotherapy in the treatment ... Despite a highly significant and clinically meaningful improvement ... p<0.0001) as measured on a 100mm unit Visual ...
Breaking Medicine Technology:Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 2Unfors RaySafe, ein Unternehmen von Fluke Biomedical, stellt auf European Congress of Radiology neuen Überwachungssensor vor 3Hill-Rom Elects Stacy Enxing Seng to its Board of Directors 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 2Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 3Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 4Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 5Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 6Vanda Pharmaceuticals Announces Tradipitant Phase II Proof of Concept Study Results for Chronic Pruritus in Atopic Dermatitis 7
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: